This inventor holds 6 USPTO granted patents. Top assignee: Fisons Ltd.. Active years: 1979-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- East Leake, GB (1983)
- Loughborough, GB (1979 - 1993)
Company Filing History:
Years Active: 1979-1993
Title: The Innovative Contributions of Kenneth Brown
Introduction
Kenneth Brown is a notable inventor based in Loughborough, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions for treating respiratory conditions. With a total of 6 patents to his name, his work has had a meaningful impact on medical treatments.
Latest Patents
Among his latest patents is a pharmaceutical composition that includes 9-ethyl-6,9-dihydro-4,6-dioxo-10-propyl-4H-pyrano[3,2-g]quinoline-2,8-dicarboxylic acid or a pharmaceutically acceptable salt thereof. This composition is designed for the treatment of reversible obstructive airways disease and incorporates a pressurized or liquefied gas propellant along with flavoring and/or sweetening agents. Notably, it contains nedocromil sodium as the active ingredient, with flavoring agents such as menthol and peppermint oil, and sweetening agents including sugar and aspartame. The composition is ideally packaged in a conventional pressurized aerosol canister fitted with a dispensing metering valve.
Career Highlights
Kenneth Brown has been associated with Fisons Ltd., where he has contributed to the advancement of pharmaceutical formulations. His innovative approaches have led to the development of new forms of nedocromil sodium and methods for producing these forms. His work primarily focuses on pressurized inhalation aerosol formulations that are effective for treating reversible obstructive conditions of the airways.
Collaborations
Throughout his career, Kenneth has collaborated with notable colleagues such as Andrew R Clark and Richard Salliss. These partnerships have fostered a collaborative environment that enhances the innovation process within the pharmaceutical industry.
Conclusion
Kenneth Brown's contributions to pharmaceutical innovations demonstrate his commitment to improving respiratory treatments. His patents reflect a deep understanding of medical needs and a dedication to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile